Healthcare
Zecotek Photonics Inc.(ZMSPF)
Live Price
Offline$0.00001
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 โ Jun 17, 2026
- Market Cap
- โ
- Revenue Growth
- -44.3%
- EPS Growth
- +8.8%
- Dividend Yield
- 0.0%
Coverage: 248 bars ยท Jun 23, 2025 โ Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Zecotek Photonics Inc. (ZMSPF) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 โ Jun 17, 2026). Baseline metrics include revenue growth of -44.3%, EPS growth of +8.8%, a dividend yield of 0.0%. What stands out right now is revenue -44.3%, EPS +8.8%, free cash flow -21.6% with operating margin -4222.1% and ROIC 4951.3%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines ZMSPF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-44.3% vs +7.6% peer median
Operating Margin
Below sector median
-4222.1% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2024 was reported on Oct 2, 2024, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -44.3% and EPS is at +8.8%, with operating margin around -4222.1%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2024 Oct 2, 2024 | โ | +0.0% | +0.0% | +0.0% |
2024 Jul 3, 2024 | โ | +0.0% | +0.0% | +0.0% |
2024 Apr 3, 2024 | โ | +0.0% | +0.0% | +0.0% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
ZMSPF
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
ZMSPF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for ZMSPF and SPY.
Company Overview
Zecotek Photonics Inc.
Other OTC
Zecotek Photonics Inc., a photonics technology company, develops various photonics technologies and products for commercial and research applications in medical, bio-science, high-energy physics, pharmaceutical research, material processing, engineering and industrial design, and multi-media markets in Canada. The company operates through three divisions: Zecotek Imaging China, Zecotek Optronics Systems, and Zecotek Autotronics. Its imaging systems include lutetium fine silicate scintillation crystals; solid-state micro-pixel avalanche photo diode photo detectors and transistors; and integrated detector modules. The company also develops glasses-free 3D displays; and 3D auto-stereoscopic displays, and 3D printers and related technologies. The company was formerly known as Zecotek Medical Systems Inc. and changed its name to Zecotek Photonics Inc. in November 2007. Zecotek Photonics Inc. was incorporated in 1983 and is headquartered in Richmond, Canada.
- Leadership
- Jiang Chen
- IPO Date
- Jul 10, 2009
- Street Address
- 6900 Graybar Road
- Mailing
- Richmond, BC, V6W 0A5
- Region
- Richmond, BC, CA
- Reporting Currency
- USD
- Investor Line
- 604-233-0056
- Last Updated
- May 6, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 0.0
- Price/Book
- โ
Growth
- Revenue
- -44.3%
- EPS
- +8.8%
- Free Cash Flow
- -21.6%
Profitability
- Gross Margin
- -225.5%
- Operating Margin
- -4222.1%
- Net Margin
- -4063.0%
- ROE
- 82.4%
- ROIC
- 4951.3%
Balance Sheet
- Debt/Equity
- โ
- Current Ratio
- 0.17
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.